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The 39-item Parkinson’s disease questionnaire (PDQ-39) is the most widely used patient-reported rating scale in Parkinson’s
disease (PD). However, recent studies have questioned its validity and it is unclear what scores represent. This study explored
the possibility of regrouping PDQ-39 items into scales representing the International Classiﬁcation of Functioning, Disability,
and Health (ICF) components of Body Functions and Structures (BF), Activities and Participation (AP), and Environmental (E)
factors. An iterative process using Rasch analysis produced ﬁve new items sets, two each for the BF and AP components and one
representing E. Four of these were found to represent clinically meaningful variables: Emotional Impairment (BF), Gross Motor
Disability(AP),FineMotorDisability(AP),andSocioattitudinalEnvironment(E)withacceptablereliability(0.73–0.96)andﬁtto
the Rasch model (total item-trait chi-square, 8.28–33.2; P>. 05). These new ICF-based scales oﬀer a means to reanalyze PDQ-39
data from an ICF perspective and to study its health components using a widely available health status questionnaire for people
with PD.
1.Introduction
The International Classiﬁcation of Functioning, Disability,
andHealth(ICF)providesaconceptualisationandclassiﬁca-
tion of diﬀerent components of health including biological,
individual, and social perspectives [1]. The ICF contains two
parts. The ﬁrst part deﬁnes functioning and disability, which
in turn consists of two components, Body Functions and
Structures, and Activities and Participation. Body functions
include physiological and psychological functions, and body
structures refer to the anatomical integrity of the body.
Activities are the execution of tasks or actions, whereas
participation refers to the involvement in life situations.
The second part conceptualizes contextual factors, which
include environmental and personal factors. The environ-
mental component is the facilitating or hindering impact of
the physical, social, and attitudinal environment. Similarly,
personal factors are recognized as having a facilitating or
hindering impact but they are not further speciﬁed because
of their vast social and cultural variation [1].
In addition to its use for clinical, educational, and
research purposes, the ICF can be used to understand the
content of diﬀerent health outcome measures [2]. Linking
such scales to the ICF can be valuable to allow clinical
studies to relate to the ICF and for gaining a conceptual
understanding of scale contents [3, 4], thereby serving as a
base for their further development and reﬁnement. Rules for
linkinghealthstatusmeasurestotheICFhavebeenproposed
and used for linking items of various generic and disease
speciﬁc scales to the ICF [2, 5, 6]. The ﬁndings from such
studies can guide researchers and clinicians in their selection
of instruments for speciﬁc purposes.
The 39-item Parkinson’s disease questionnaire (PDQ-39)
[7] is the most widely used patient-reported rating scale
in Parkinson’s disease (PD). However, recent studies have
identiﬁed problems with its measurement properties. For2 Parkinson’s Disease
Table 1: Sample characteristics (n = 202).
Gender (men/women), n (%) 108 (53.5)/94 (46.5)
Age (years), Mean (SD;
min–max) 69.8 (10.0; 34–90)
Retired, n (%) 143 (70.8)
Married or cohabitant, n (%) 144 (71.2)
Living in own home, n (%) 179 (88.6)
Disease duration (years),
Mean (SD; min–max) 8.7 (6.6; 0.5–28)
Hoehn and Yahr stage of PD
a,
Median (q1–q3; min–max) III (II–IV; I–V)
Perceived disease severityb,
Median (q1–q3; min–max) 2 (2-2; 1–3)
Motor ﬂuctuationsc, n (%) 137 (67.8)
aAs assessed for the “oﬀ” phase from clinical records. Range, I–V (I = mild
unilateral disease; V = Conﬁned to bed or wheelchair unless aided) [13].
bSelf-rated as mild (= 1), moderate (= 2 ) ,o rs e v e r e( = 3).
cSelf-reported as present or absent.
PD, Parkinson’s disease; SD, standard deviation.
instance, while the instrument as a whole, as well as its 8-
item short form (PDQ-8), appears multidimensional, the
validity of the suggested grouping of its items into eight
scales also appears questionable [8–10]. Consequently, its
validity is at stake as it is unclear what scores represent.
Other problems have included suboptimal targeting (items
represent more severe health problems than those expe-
rienced by people with PD) compromised measurement
precision and problems associated with the use of its ﬁve
responsecategories[8–10].Althoughtheseexperiencespoint
to the need for new developments in patient-reported health
outcome measurement for PD, the wide use and spread of
the PDQ-39 argues for consideration of alternative and more
validmeansofusingthequestionnaire.Onewaytotacklethe
validity problems of the PDQ-39 could be to regroup items
into theoretically more interpretable domains based on their
linkage to the ICF, since this is a universal and standardized
nomenclature of functioning and health [11]. Such linking
andregroupingofitemsneedtobefollowedbypsychometric
analyses and reﬁnement, which preferably is done by means
of the Rasch measurement model [12].
Here we explore the possibility of regrouping PDQ-39
items according to the ICF framework and test these new
scales psychometrically using Rasch analysis.
2. Methods
2.1. Sample. Details have been reported elsewhere [14].
Brieﬂy, self-reported postal survey PDQ-39 data from 202
people (79% response rate) with neurologist-diagnosed PD
were analyzed (Table 1). The sample consisted of people with
PD seen at a South Swedish university hospital during one
year, excluding those in terminal care and participants in
other recent or ongoing questionnaire-based studies. The
survey included a question about whether the participant
had responded to the questions him-/herself; only respon-
dents who reported that they had answered the survey
themselves were included. The study was conducted in
accordance with the Declaration of Helsinki, all subjects
consented to participation, and the study was approved by
the local research ethics committee.
2.2. The PDQ-39. The PDQ-39 [7] is a PD speciﬁc health
status questionnaire comprising 39 items that are grouped
into eight scales (Mobility, Activities of Daily Living, Emo-
tional well being, Stigma, Social Support, Cognitions, Com-
munication, and Bodily Discomfort). In addition, an overall
PDQ-39 summary index (PDQ-39SI) that summarizes the
eight scale scores has been proposed [15]. Respondents are
requested to aﬃrm one of ﬁve ordered response categories
according to how often (from never to always), due to their
PD, they have experienced the problem deﬁned by each item
during the past month. Higher scores indicate more frequent
problems.
2.3. Procedure. The 39 items were linked to the ICF by three
health science researchers experienced with the ICF and rep-
resenting diﬀerent disciplines (nursing, physical therapy and
occupational therapy) [2]. First, the 39 items were linked to
the most appropriate ICF components (Body Functions and
Structures, Activity and Participation, Environment) by each
researcher individually. Each item could be linked to more
than one component and category [2]. If the information
provided by an item was insuﬃcient to allow linkage to
an ICF category, the item was considered “not deﬁnable”.
The researchers discussed their results in two consensus
meetings. At the ﬁrst meeting preliminary consensus were
reached. In the second meeting remaining classiﬁcation
diﬃculties were resolved and items were rearranged into
three groups representing the ICF components of Body
Functions and Structures (BF), Activities and Participation
(AP), and Environment (E).
2.4. Data Analysis. Each of the three item groups was indi-
vidually analyzed psychometrically according to the Rasch
measurement model [16] for ordered response categories
(the partial credit model) [17, 18].
2.4.1. The Rasch Model. The Rasch model [16, 17, 19]
deﬁnes, mathematically, what is required from data (item
responses) for total scores to express valid measurement. The
model is based on the notion that the probability of a certain
item response is a logistic function of the diﬀerence between
the person’s location on the measured variable and the level
of the variable represented by the item. The model separately
locatespersons anditems onacommonlogit(log-odd units)
metric, with the mean item location set at zero logits. The
Rasch model requires unidimensionality (items represent a
common underlying latent variable) and local independence
(each item response provides unique information). Both
these aspects are reﬂected in the ﬁt of data to the model and
violation of either distorts measurement [20, 21].Parkinson’s Disease 3
Model ﬁt is assessed by examining the accordance
between expected and observed responses across person
locations (class intervals) on the measured construct [17,
19]. Overall ﬁt is supported by a nonsigniﬁcant item-trait
interaction chi-square statistic, and individual item ﬁt is
supported by non-signiﬁcant standardized residuals that
range between −2.5a n d+ 2 .5[ 17, 19]. Residuals repre-
sent the discrepancy between observed and expected item
responses. Large negative residuals signal local dependency,
whereas large positive residuals primarily suggest violation
of unidimensionality.
However, ﬁt statistics can be somewhat insensitive in
detecting multidimensionality [22, 23]. Smith [22] therefore
proposed conducting a principal component analysis (PCA)
of the residuals to identify potential subdimensions in the
scale, followed by a series of independent t-tests to assess
whether subsets of items yield diﬀerent person measures.
If violation of unidimensionality is trivial, the number of
person locations that diﬀer between the two item sets is
small. This approach attempts to assess whether scales are
suﬃciently unidimensional to be treated as such in practice
[22, 24].
The Rasch model also provides a means to assess
whether response categories work as assumed [17]. Ordered
responsecategories(e.g.,0-1-2-3-4)areexpectedtoreﬂectan
increasing amount of the variable under investigation. The
threshold between two adjacent categories is the point where
there is a 50/50 probability of scoring, for example, 2 or 3.
Disordered thresholds (e.g., if the 50/50 probability point
betweenscoring3or4occursatalowerlevelofthemeasured
construct than that between scoring 2 or 3) indicate that
the response categories do not work as intended. Disordered
thresholds may be due to multidimensionality, too many
response options, or ambiguous wording. Collapsing cate-
gories with disordered thresholds may improve model ﬁt
and provide clues regarding how the scale may be improved
[25, 26].
Diﬀerential item functioning (DIF) is an additional
aspect of ﬁt to the Rasch model that may result from
multidimensionality and can give biased scale scores [19].
DIFanalysesassesswhethersubgroupsofpeoplewithsimilar
levels on the measured construct respond systematically
diﬀerent to items [27]. When DIF is uniform (i.e., item
responses diﬀer uniformly between groups across the mea-
sured construct), this can be adjusted for by splitting the
item into two new items, one for each subgroup [17]. If this
does not improve model ﬁt, the item may be involved in
multidimensionality and can be considered for removal.
Targeting assesses how well a scale corresponds to the
levels of, for example, health impairments experienced by
respondents, by comparing the locations of persons and
items. If scales are well targeted to the sample the mean
sample location should approximate the mean item location
(i.e., zero). Examination of the relationship between the
locations of people and item response category thresholds
also reveals how successful a set of items are in mapping
out a continuum of relevant levels of the measured variable
[28, 29]. Targeting also has implications for model ﬁt; when
targeting is poor, the ability to assess ﬁt is compromised.
Similarly, compromised reliability with poorly separated
persons also reduces the ability to detect misﬁt [17, 19, 28].
2.4.2. Analysis Plan. The overall aim of the analyses was to
achieve well ﬁtting and clinically interpretable scales without
disordered response thresholds or DIF by gender or age.
When analyzing the new item groups the following general
approach was therefore taken. First, we deleted not deﬁnable
items and items that were classiﬁed into more than one ICF
component. However, since only one item was considered a
“pure”environmentalitem(seeSection 3),wecombinedthis
with items classiﬁed as environmental in addition to tapping
either the BF or AP components.
The resulting item groups were then checked for signs
of multidimensionality by means of PCA of the residuals
followedbyindependentt-testcomparisonsoftwoestimated
locations for each person, one based on the items with pos-
itive and one from the items with negative residual loadings
on the ﬁrst principal component [24]. Unidimensionality
was considered statistically supported if the proportion of
signiﬁcant individual t-tests, or the lower bound of the
associated 95% binomial conﬁdence interval (CI), did not
exceed 0.05 [24]. In case of multidimensionality, items were
regrouped according to results of the PCA and theoretical
considerations and then analyzed further as separate scales.
Functioning of response categories was then examined,
and if disordered thresholds were found, categories were
collapsed. If ﬁt did not improve, items were deleted one
at a time, starting with the most misﬁtting item, while
monitoring the resulting overall and item level ﬁt at each
stage. The presence of DIF was assessed by comparing item
response functions between genders and age groups (as
deﬁned by the median, <72 versus ≥72 years old). In case
of DIF, these items were split into two new items (one for
each subgroup). If this did not improve the scale, the item
was deleted.
The resulting scales were examined regarding reliability
and targeting. Reliability was assessed by the person separa-
tion index (PSI) [30], which is analogous to coeﬃcient alpha
and should exceed 0.7. We also assessed targeting (i.e., how
well item locations accorded with the location of the sample)
and the extent to which the points of measurement (i.e.,
the locations of response category thresholds) mapped out
an evenly spaced quantitative continuum without signiﬁcant
gaps (indicating compromised measurement ability and
larger measurement error) or clustering (indicating item
measurement redundancy) [28]. Finally, the logic of the
hierarchical ordering of item locations within each scale
was considered in order to assess their internal content
and construct validity. That is, do item contents appear
to represent clinically interpretable variables and is their
hierarchical ordering reasonably congruent with increasing
and decreasing levels on that variable?
All analyses were conducted using the RUMM2020
software (Rumm Laboratory Pty Ltd., Perth). Due to the
large number of statistical tests, P-values were adjusted
according to Bonferroni [31].4 Parkinson’s Disease
3. Results
Of the 39 items, 30 were judged to belong to only one ICF
component (BF, 13 items; AP, 16 items; E, 1 item), eight were
judged to belong to two ICF components, and one item was
considered not deﬁnable (Table 2).
Data quality was good with an average of 2% missing
item responses. Rasch analyses of the three item sets showed
signiﬁcant (P<. 0001) overall misﬁt with total item-
traitinteractionchi-squarevaluesof69.12(BF),132.36(AP),
and 77.67(E). Reliabilities were 0.90(BF), 0.95(AP), and
0.80(E). Item level ﬁt statistics are shown in Table 3.P C A
followed by independent t-tests showed that the proportions
of signiﬁcantly diﬀerent person measures were 0.15 (95%
CI, 0.12–0.18) for the BF items, 0.18 (0.15–0.21) for the
AP items, and 0.05 (0.02–0.08) for the environmental items.
Based on these ﬁndings and conceptual considerations, BF
and AP items were then grouped into two subdimensions
each (a and b, resp.) before further analyses: BFa (items
17–22), BFb (items 30–33 and 37–39), APa (items 1–7, 11,
12), and APb (items 13–16, 24, 27, 35). The new BF and
AP scales displayed improved model ﬁt with total item-trait
interaction chi-square values of 10.39 (P = .582; BFa), 24.81
(P = .036; BFb), 42.24 (P = .001; APa), and 28.9 (P = .011;
APb). Reliabilities were 0.90(BFa), 0.78(BFb), 0.96(APa),
and 0.87(APb).
Examination of the response categories revealed disor-
dered thresholds in none (BFa and APb), 5(BFb), 3(APa)
and 4(E) items. Items 30, 31, 33, 37, and 39(BFb) and
items 3, 11, and 12(APa) were rescored into four categories
(01123). Items 8, 23, 28, and 29(E) needed to be reduced
to three categories (01112). Figure 1 shows an example
(item 28) of response category functioning before and after
rescoring.
Subsequent stepwise item reduction guided by ﬁt and
DIF statistics rendered the new item sets comprising ﬁve
(BFa) to eight (APa) items each (Table 4). Total item-trait
interaction (P>. 056) and item level ﬁt statistics (Table 4)
suggested reasonable ﬁt in all ﬁve instances, and reliabilities
ranged between 0.73(BFa) and 0.96(APa). Figure 2 illus-
trates the locations of item response category thresholds
relative to the locations of the sample for each item set.
Inspection of these graphs shows a general tendency for the
items (bars below the x-axes) to represent worse health than
that experienced by the persons (bars above the x-axes).
Furthermore, while the thresholds are able to map out a
continuum for each scale, there are also several gaps as well
as clusters along those continua (Figure 2).
4. Discussion
This study aimed at improving the validity of the PDQ-39
by linking its items to the ICF and to use this as a basis
for deﬁning new scales that are more interpretable than the
originally proposed eight PDQ-39 scales and its summary
index.Resultsprovidesupportforthenotionthatthistypeof
exercise is useful in improving the conceptual understanding
of health status questionnaires such as the PDQ-39, whose
development was not conceptually but primarily data-driven
Table 2: ICF classiﬁcation of PDQ-39 items.
Item ICF classiﬁcation
No. Contents (abridged)
1 Leisure activities AP
2 Looking after home AP
3 Carry shopping bags AP
4 Walking half a mile AP
5 Walking 100 yards AP
6 Getting around the house AP
7 Getting around in public AP
8 Need company when going out AP + E
9 Worry falling in public BF + AP
10 Conﬁned to the house ND
11 Washing AP
12 Dressing AP
13 Do buttons or shoe laces AP
14 Writing clearly AP
15 Cutting food AP
16 Hold a drink without spilling AP
17 Depressed BF
18 Isolated and lonely BF
19 Weepy or tearful BF
20 Angry or bitter BF
21 Anxious BF
22 Worried about the future BF
23 Felt need to conceal PD BF + E
24 Avoid eating/drinking in public AP
25 Embarrassed due to PD BF + E
26 Worried about people’s reactions BF + E
27 Close relationships AP
28 Support from partner AP + E
29 Support from family or friends E
30 Unexpectedly fallen asleep BF
31 Concentration BF
32 Poor memory BF
33 Distressing dreams or
hallucinations
BF
34 Speech BF + AP
35 Unable communicate properly AP
36 Felt ignored BF + E
37 Painful cramps or spasms BF
38 Pain in joints or body BF
39 Unpleasantly hot or cold BF
ICF: International Classiﬁcation of Functioning, Disability and Health;
AP: Activity and Participation; BF: Body Functions and Structures; E:
Environment; ND: not deﬁnable.
through correlational observations such as factor analysis.
Our observations also illustrate that the PDQ-39 can be
used to assess the health impact of PD according to the ICF
framework by regrouping items and treating them as new
scales.Parkinson’s Disease 5
Table 3: Rasch item and ﬁt statistics for the initial ICF scales of the PDQ-39a.
Item statisticsb Fit statisticsb
Component Item Locationc SE
c Residual
d Chi squaree,f F-statistic
e,g
BF 17 −0.61 0.09 −1.65 11.30 8.69
18 0.10 0.08 −1.08 2.70 2.12
19 0.48 0.09 −0.15 2.39 1.44
20 0.30 0.09 −0.44 3.11 1.60
21 −0.27 0.09 −0.99 9.59 5.99
22 −0.35 0.09 −0.83 7.24 4.47
30 0.73 0.08 2.98 10.32 4.12
31 −0.08 0.08 −0.68 4.42 2.82
32 −0.10 0.08 2.52 2.22 1.19
33 0.77 0.08 0.70 0.67 0.36
37 0.01 0.07 2.18 3.80 1.69
38 −0.64 0.08 1.92 3.62 1.87
39 −0.33 0.08 2.25 7.76 3.19
AP 1 −0.64 0.09 −0.38 0.56 0.48
2 −0.47 0.08 −2.06 4.65 4.05
3 −0.54 0.07 −0.56 0.74 0.26
4 −0.60 0.07 −0.09 1.11 0.12
50 .22 0.08 −0.88 5.21 3.56
6 −0.18 0.08 −2.45 12.00 10.61
7 −0.45 0.08 −3.96 18.34 21.79
11 0.79 0.09 −2.27 10.54 9.84
12 0.25 0.08 −2.04 5.52 4.67
13 −0.42 0.08 0.35 4.75 2.47
14 −0.73 0.09 2.01 12.64 6.26
15 −0.01 0.08 0.92 2.82 1.72
16 0.44 0.08 3.74 10.45 3.74
24 0.48 0.09 2.91 9.05 3.55
27 1.50 0.10 3.07 31.34 12.40
35 0.36 0.08 2.27 2.62 1.23
E8 −0.80 0.06 3.55 34.74 13.72
23 −0.14 0.08 0.50 1.97 0.83
25 −0.22 0.08 −0.82 10.90 8.22
26 0.11 0.09 −0.30 12.94 8.25
28 0.08 0.10 0.58 4.74 1.68
29 0.42 0.09 −0.04 5.49 2.38
36 0.55 0.10 −0.95 6.90 4.04
aPerformed with the sample divided into three class intervals according to person locations on the measured construct.
bRounded to two decimals.
cExpressed in linear log-odds units (logits). Mean item location is zero with positive values representing more health problems.
dResiduals summarize the deviation of observed from expected responses. Deviation from the recommended range from −2.5t o+ 2 .5, indicatingitem misﬁt,
are bold.
eBonferroni corrected statistically signiﬁcant deviations across class intervals, indicating item misﬁt, is bold.
fChi-square values summarize the deviation of observed from expected responses across the three class intervals of people. Higher values represent larger
deviations.
gF-statistics from one-way ANOVAs of deviations from model expectation across the three class intervals of people.
ICF: International Classiﬁcation of Functioning, Disability and Health; AP: Activity and Participation; BF: Body Functions and Structures; E: Environment;
SE: standard error.
Although the linking procedure employed here means
that each of the item sets relate to the respective components
of the ICF, these components are in themselves (i.e., without
any further speciﬁcation) relatively unspeciﬁc and broad in
nature. As such, they only provide a basic framework as to
what variables the new PDQ-39-based item sets represent.
For the responses to a set of items to be meaningfully
summarized into a total score and interpreted as a measure6 Parkinson’s Disease
T
a
b
l
e
4
:
R
a
s
c
h
i
t
e
m
a
n
d
ﬁ
t
s
t
a
t
i
s
t
i
c
s
f
o
r
t
h
e
ﬁ
n
a
l
I
C
F
s
c
a
l
e
s
o
f
t
h
e
P
D
Q
-
3
9
a
.
C
o
m
p
o
n
e
n
t
I
t
e
m
s
b
I
t
e
m
s
t
a
t
i
s
t
i
c
s
c
F
i
t
s
t
a
t
i
s
t
i
c
s
c
T
o
t
a
l
i
t
e
m
-
t
r
a
i
t
P
S
I
h
N
o
.
C
o
n
t
e
n
t
(
a
b
r
i
d
g
e
d
)
L
o
c
a
t
i
o
n
d
S
E
d
R
e
s
i
d
u
a
l
e
C
h
i
s
q
u
a
r
e
f
F
-
s
t
a
t
i
s
t
i
c
g
C
h
i
-
s
q
u
a
r
e
(
P
-
v
a
l
u
e
)
B
F
a
1
7
D
e
p
r
e
s
s
e
d
−
0
.
6
5
0
.
1
1
−
1
.
1
6
2
.
0
4
1
.
6
1
1
2
.
4
6
(
0
.
4
1
)
0
.
7
3
2
2
W
o
r
r
i
e
d
a
b
o
u
t
t
h
e
f
u
t
u
r
e
−
0
.
3
1
0
.
1
1
0
.
5
3
0
.
7
7
0
.
3
9
2
1
A
n
x
i
o
u
s
−
0
.
1
6
0
.
1
2
−
0
.
7
4
1
.
8
8
1
.
4
4
1
8
I
s
o
l
a
t
e
d
a
n
d
l
o
n
e
l
y
0
.
4
2
0
.
1
0
0
.
5
2
0
.
5
1
0
.
1
8
2
0
A
n
g
r
y
o
r
b
i
t
t
e
r
0
.
7
0
0
.
1
1
1
.
6
2
1
.
0
0
0
.
5
8
B
F
b
3
8
P
a
i
n
i
n
j
o
i
n
t
s
o
r
b
o
d
y
−
1
.
0
2
0
.
0
8
−
0
.
2
1
0
.
2
9
0
.
1
8
6
.
1
5
(
0
.
8
0
2
)
0
.
8
8
3
2
P
o
o
r
m
e
m
o
r
y
−
0
.
4
6
0
.
0
9
0
.
9
4
1
.
0
4
0
.
6
2
3
9
U
n
p
l
e
a
s
a
n
t
l
y
h
o
t
o
r
c
o
l
d
−
0
.
4
6
0
.
1
1
−
0
.
1
5
2
.
2
1
1
.
3
1
3
7
P
a
i
n
f
u
l
c
r
a
m
p
s
o
r
s
p
a
s
m
s
−
0
.
0
6
0
.
1
0
−
0
.
6
3
5
.
2
8
3
.
7
2
3
0
U
n
e
x
p
e
c
t
e
d
l
y
f
a
l
l
e
n
a
s
l
e
e
p
0
.
9
5
0
.
1
2
2
.
0
6
2
.
2
6
1
.
0
5
3
3
D
i
s
t
r
e
s
s
i
n
g
d
r
e
a
m
s
o
r
h
a
l
l
u
c
i
n
a
t
i
o
n
s
1
.
0
5
0
.
1
2
0
.
1
3
1
.
3
8
0
.
8
2
A
P
a
1
L
e
i
s
u
r
e
a
c
t
i
v
i
t
i
e
s
−
0
.
9
3
0
.
1
1
2
.
2
3
8
.
8
1
3
.
8
3
3
3
.
2
(
0
.
0
0
7
)
i
0
.
9
6
4
W
a
l
k
i
n
g
h
a
l
f
a
m
i
l
e
−
0
.
7
9
0
.
0
9
0
.
5
9
2
.
1
6
1
.
3
4
7
G
e
t
t
i
n
g
a
r
o
u
n
d
i
n
p
u
b
l
i
c
−
0
.
6
2
0
.
1
0
−
2
.
3
6
3
.
4
3
3
.
5
1
2
L
o
o
k
i
n
g
a
f
t
e
r
h
o
m
e
−
0
.
6
0
0
.
1
0
0
.
9
2
2
.
4
7
0
.
9
3
6
G
e
t
t
i
n
g
a
r
o
u
n
d
t
h
e
h
o
u
s
e
−
0
.
2
4
0
.
1
0
−
0
.
5
7
2
.
2
2
1
.
4
4
5
W
a
l
k
i
n
g
1
0
0
y
a
r
d
s
0
.
4
5
0
.
1
0
−
0
.
2
3
7
.
4
0
4
.
2
4
1
2
D
r
e
s
s
i
n
g
0
.
7
8
0
.
1
4
1
.
0
3
0
.
7
9
0
.
2
8
1
1
W
a
s
h
i
n
g
1
.
9
5
0
.
1
4
−
0
.
5
4
5
.
9
1
3
.
6
4
A
P
b
1
4
W
r
i
t
i
n
g
c
l
e
a
r
l
y
−
0
.
7
7
0
.
0
9
−
0
.
3
0
1
.
5
4
1
.
1
3
8
.
2
8
(
0
.
6
0
)
0
.
8
6
1
3
D
o
b
u
t
t
o
n
s
o
r
s
h
o
e
l
a
c
e
s
−
0
.
4
0
0
.
0
8
0
.
8
4
0
.
5
1
0
.
1
9
1
5
C
u
t
t
i
n
g
f
o
o
d
0
.
0
1
0
.
0
9
−
0
.
4
1
3
.
6
9
2
.
9
4
1
6
H
o
l
d
a
d
r
i
n
k
w
i
t
h
o
u
t
s
p
i
l
l
i
n
g
0
.
5
6
0
.
0
9
0
.
6
5
2
.
0
1
0
.
9
7
2
4
A
v
o
i
d
e
a
t
i
n
g
/
d
r
i
n
k
i
n
g
i
n
p
u
b
l
i
c
0
.
5
9
0
.
0
9
1
.
4
1
0
.
5
4
0
.
2
0
E
2
5
E
m
b
a
r
r
a
s
s
e
d
d
u
e
t
o
P
D
−
0
.
8
2
0
.
0
9
−
1
.
2
7
1
.
8
6
1
.
2
7
1
3
.
4
2
(
0
.
3
4
)
0
.
8
2
2
6
W
o
r
r
i
e
d
a
b
o
u
t
p
e
o
p
l
e
’
s
r
e
a
c
t
i
o
n
s
−
0
.
4
1
0
.
1
0
−
1
.
6
4
2
.
8
5
2
.
3
2
2
3
F
e
l
t
n
e
e
d
t
o
c
o
n
c
e
a
l
P
D
−
0
.
2
0
0
.
1
6
−
0
.
0
5
1
.
9
2
1
.
1
5
3
6
F
e
l
t
i
g
n
o
r
e
d
0
.
1
2
0
.
1
0
0
.
9
7
3
.
7
9
1
.
9
8
2
8
S
u
p
p
o
r
t
f
r
o
m
p
a
r
t
n
e
r
0
.
3
8
0
.
1
8
1
.
2
5
2
.
7
3
1
.
2
8
2
9
S
u
p
p
o
r
t
f
r
o
m
f
a
m
i
l
y
o
r
f
r
i
e
n
d
s
0
.
9
2
0
.
1
7
1
.
5
5
0
.
2
8
0
.
1
0
a
P
e
r
f
o
r
m
e
d
w
i
t
h
t
h
e
s
a
m
p
l
e
d
i
v
i
d
e
d
i
n
t
o
t
h
r
e
e
c
l
a
s
s
i
n
t
e
r
v
a
l
s
a
c
c
o
r
d
i
n
g
t
o
p
e
r
s
o
n
l
o
c
a
t
i
o
n
s
o
n
t
h
e
m
e
a
s
u
r
e
d
c
o
n
s
t
r
u
c
t
.
b
L
i
s
t
e
d
i
n
l
o
c
a
t
i
o
n
o
r
d
e
r
.
I
t
e
m
n
u
m
b
e
r
s
r
e
f
e
r
t
o
t
h
e
o
r
i
g
i
n
a
l
P
D
Q
-
3
9
q
u
e
s
t
i
o
n
n
a
i
r
e
.
A
t
o
t
a
l
o
f
n
i
n
e
o
r
i
g
i
n
a
l
P
D
Q
-
3
9
i
t
e
m
s
(
n
u
m
b
e
r
s
3
,
8
,
9
,
1
0
,
1
9
,
2
7
,
3
1
,
3
4
,
a
n
d
3
5
)
w
e
r
e
e
x
c
l
u
d
e
d
.
c
R
o
u
n
d
e
d
t
o
t
w
o
d
e
c
i
m
a
l
s
.
d
E
x
p
r
e
s
s
e
d
i
n
l
i
n
e
a
r
l
o
g
-
o
d
d
s
u
n
i
t
s
(
l
o
g
i
t
s
)
.
M
e
a
n
i
t
e
m
l
o
c
a
t
i
o
n
i
s
z
e
r
o
w
i
t
h
p
o
s
i
t
i
v
e
v
a
l
u
e
s
r
e
p
r
e
s
e
n
t
i
n
g
m
o
r
e
h
e
a
l
t
h
p
r
o
b
l
e
m
s
.
e
R
e
s
i
d
u
a
l
s
s
u
m
m
a
r
i
z
e
t
h
e
d
e
v
i
a
t
i
o
n
o
f
o
b
s
e
r
v
e
d
f
r
o
m
e
x
p
e
c
t
e
d
r
e
s
p
o
n
s
e
s
.
f
C
h
i
-
s
q
u
a
r
e
v
a
l
u
e
s
s
u
m
m
a
r
i
z
e
t
h
e
d
e
v
i
a
t
i
o
n
o
f
o
b
s
e
r
v
e
d
f
r
o
m
e
x
p
e
c
t
e
d
r
e
s
p
o
n
s
e
s
a
c
r
o
s
s
t
h
e
t
h
r
e
e
c
l
a
s
s
i
n
t
e
r
v
a
l
s
o
f
p
e
o
p
l
e
.
H
i
g
h
e
r
v
a
l
u
e
s
r
e
p
r
e
s
e
n
t
l
a
r
g
e
r
d
e
v
i
a
t
i
o
n
s
.
g
F
-
s
t
a
t
i
s
t
i
c
s
f
r
o
m
o
n
e
-
w
a
y
A
N
O
V
A
s
o
f
d
e
v
i
a
t
i
o
n
s
f
r
o
m
m
o
d
e
l
e
x
p
e
c
t
a
t
i
o
n
a
c
r
o
s
s
t
h
e
t
h
r
e
e
c
l
a
s
s
i
n
t
e
r
v
a
l
s
o
f
p
e
o
p
l
e
.
h
R
e
l
i
a
b
i
l
i
t
y
i
n
d
e
x
a
n
a
l
o
g
o
u
s
t
o
C
r
o
n
b
a
c
h
’
s
a
l
p
h
a
.
i
P
=
.
0
5
7
f
o
l
l
o
w
i
n
g
B
o
n
f
e
r
r
o
n
i
c
o
r
r
e
c
t
i
o
n
.
I
C
F
:
I
n
t
e
r
n
a
t
i
o
n
a
l
C
l
a
s
s
i
ﬁ
c
a
t
i
o
n
o
f
F
u
n
c
t
i
o
n
i
n
g
,
D
i
s
a
b
i
l
i
t
y
a
n
d
H
e
a
l
t
h
;
A
P
:
A
c
t
i
v
i
t
y
a
n
d
P
a
r
t
i
c
i
p
a
t
i
o
n
;
B
F
:
B
o
d
y
F
u
n
c
t
i
o
n
s
a
n
d
S
t
r
u
c
t
u
r
e
s
;
E
:
E
n
v
i
r
o
n
m
e
n
t
;
S
E
:
s
t
a
n
d
a
r
d
e
r
r
o
r
;
P
S
I
:
p
e
r
s
o
n
s
e
p
a
r
a
t
i
o
n
i
n
d
e
x
.Parkinson’s Disease 7
0.5
1
0
−5 −4 −3 −2 −1 012345
Person location (logits)
P
r
o
b
a
b
i
l
i
t
y
Lack support partner
0
1
2
3
4
28
(a)
0.5
1
0
−5 −4 −3 −2 −10 1 2 3 4 5
Person location (logits)
P
r
o
b
a
b
i
l
i
t
y
Lack support partner
0
1
2
28
(b)
Figure 1: Category probability curves depicting the probability (y-
axis)ofobservingresponsesineachcategory(0 =never;1=seldom;
2 = sometimes; 3 = often; 4 = always) relative to the location on the
measured construct (x-axis; positive values = more problems) for
item 28 before (a) and after (b) rescoring. This item was associated
with multiple disordering (thresholds 0-to-1/1-to-2 and thresholds
2-to-3/3-to-4) and needed reduction from ﬁve to three response
categories (combination of responses to categories 1, 2, and 3 into a
single category).
of a common underlying variable, the contents of the items
need to express various aspects and degrees of that variable.
That is, they should represent clinically reasonable manifes-
tations of the variable and its expressions on a continuum
ranging from less to more [28]. Scale construction should
therefore preferably begin by deﬁning the variable and its
manifestations from less to more; representative items are
then generated and selected to cover a relevant range of that
variable [32]. However, such a bottom-up approach was not
used in developing the PDQ-39 [7] and could therefore not
be adapted here either. Instead, it is necessary to consider,
based on their contents, what aspects within the respective
ICF components the resulting item sets may represent, and if
they map out clinically meaningful variables.
Examination of the item sets and the relative locations of
i t e m sw i t h i ne a c hs e t( Table 4) suggest that four psychome-
trically valid and clinically interpretable ICF indicators can
be inferred from the results of this study, That is, Emotional
Impairment (BFa), Gross Motor Disability (APa), Fine
Motor Disability (APb), and Socioattitudinal Environment
(E). Although the BFb item set exhibited good psychome-
tric properties, it appears unclear what common variable
manifestations (items) such as pain, poor memory, feeling
unpleasantlyhotorcold,andhallucinationswouldrepresent.
As this item set originates from two of the original PDQ-
39 scales (Cognitions, items 30, 32, 33; Bodily Discomfort,
items 37–39), it could be suggested to split BFb according to
these scales. However, this resulted in considerably reduced
measurement precision and reliability (data not shown), and
previous studies have shown that these scales are of dubious
value according to classical as well as modern test theory
analyses [10, 33, 34].
Whereas the exact labels of the four suggested ICF
indicators may be open for debate, they appear to map out
clinically meaningful variables. Table 4 lists each item set
according to their locations in the logit metric, where lower
values represent less problems relative to items with higher
values. This ordering signiﬁes the hierarchical structure of
the contents of the variable as manifested by each item
set. The hierarchy can therefore be seen as representing the
most likely experiences as people progressively move from
better to worse health and, similarly, the most probable
experiences among people with varying levels of health. As
such, it provides a means of judging their clinical feasibility
and validity [28, 29, 32]. For example, inspection of the
Fine Motor Disability (APb) items suggests that, among the
included activities, handwriting is the one that is aﬀected
earliest, followed by the ability to do buttons and shoe
laces, cut food, and hold a drink without spilling. Finally,
at relatively high levels of disability, people avoid eating or
drinking in public. This hierarchical pattern seems clinically
reasonable and suggests that the items map out various levels
of the variable.
However, it is also evident that the item sets fail to
cover the levels of disability experienced by the sample,
but tend to represent poorer health. This is reﬂected by
the mean person logit locations (which all are negative),
and by the relative distributions of item response category
thresholds and persons along the common quantitative
continua (Figure 2). This could be due to a sample bias
towards people with uncharacteristically mild PD. However,
the demographic characteristics of the sample suggest that
this is not a major explanation. That is, the respondents
appear to represent fairly representative and wide ranges of
PD severities (according to Hoehn and Yahr [13] stages),
durations and ages. In addition, a majority experienced
motor ﬂuctuations, which also speaks against a sample bias
towards mild PD.
In addition to a general bias towards poorer health states,
there are also several gaps and clusters of item response
category thresholds (see, e.g., the BFa item set; Figure 2(b)).
This means that people located around areas associated with
g a p sa r em e a s u r e dw i t hl e s sp r e c i s i o na n dt h a td i ﬀerences
and changes at these levels will be more diﬃcult to detect
[28, 29]. These problems are well known also for the original
PDQ-39[9,10]andwouldnotbeexpectedtoresolvewithout
the addition of new items representing areas not covered by
available items [28, 29].8 Parkinson’s Disease
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Figure 2: Distributions of the locations of people (upper histogram in each panel) and response category thresholds (lower histogram in
each panel) on the common logit metric (positive values = more problems). Response category thresholds are the locations where there is a
50/50 probability of endorsing either of two adjacent categories and represent the quantitative “notches” on the latent ruler deﬁned by a set
of items. (a) Item set BFa (items 17, 18, 20–22); (b) Item set BFb (items 30, 32, 33, 37–39); (c) Item set APa (items 1, 2, 4–7, 11, 12); (d) Item
set APb (items 13–16, 24); (e) Item set E (items 23, 25, 26, 28, 29, 36). Mean (SD) person locations are BFa (panel (a)), −1.115 (1.951); BFb
(panel (b)), −1.363 (1.096); APa (panel (c)), −0.814 (2.326); APb (panel (d)), −0.671 (1.370); E (panel (e)), −1.967 (1.355).
When selecting the initial item pool for each of the
ICF components, it was decided to use only items that
were linked to no more than one ICF component. This
decisionwasmadeinordertoenhanceconceptualclarityand
interpretability of item sets. However, this strategy could not
be pursued for the environmental items since only one item
was considered a “pure” environmental item. This means
that the resulting Socioattitudinal Environment item set
(E) is less speciﬁc than the other identiﬁed ICF indicators.
However, we still believe that these items can be useful as an
indicator of socioattitudinal environment in studies wishing
to address this component of the ICF, particularly since we
are unaware of any other available tool for this purpose in
people with PD.Parkinson’s Disease 9
It may also be argued that Activity and Participation
should be separated. However, the ICF provides no clear
guidance in this respect. Instead, because of diﬃculties
distinguishing between the two, the ICF oﬀers alternative
options for structuring the relationship between them [1,
35], and practices among authors vary [36]. Since the PDQ-
39wasnotdevelopedaccordingtotheconceptualframework
of the ICF, it was decided not to separate between activities
and participation in this study. Arguably, however, and
depending on exact deﬁnitions, the vast majority of items
linked to this combined AP component (and the resulting
scales) appear to represent activity limitations.
As with the original PDQ-39 and PDQ-8 [8–10], the
ﬁve-category response scale did not work as intended in
the new item sets. Although this was compensated for by
reducing the number of response categories in the analyses
conducted here, it must be emphasized that this exercise is
an exploratory post hoc one. Further developmental work
and empirical conﬁrmation that reducing and/or rephrasing
response categories improve this aspect of the questionnaire
is therefore needed.
The PDQ-39-derived ICF indicators identiﬁed here do
not represent the full ICF spectrum but only limited
aspects of its components. For example, it does not oﬀer
the possibility to study impairments of body function in
terms of the motor symptoms of PD. Furthermore, as with
the original PDQ-39 scales, targeting problems prohibit
detailed documentation of diﬀerences and changes within
the respective ICF components, which renders the new
item sets relatively coarse. However, this is not likely to
be a major problem for their use as survey tools and in
other situations where measurement precision may not be
of primacy. These limitations of the PDQ-39-derived ICF
indicators also point to the need for developing new ICF
related tools for use as clinical PD trial outcome measures.
Such scales need to be developed from explicit operational
deﬁnitions of various aspects of the ICF components and
should comply with requirements for rating scales to be
used as clinical trial outcome measures [37]. Finally, there
is a need to reassess the psychometric properties of the
PDQ-39-derived ICF indicators in additional samples and
cultures in order to establish whether they provide stable and
invariant measurement across subgroups of people beyond
those studied here.
5. Conclusions
This study illustrates that the PDQ-39 can be used to derive
psychometrically and clinically acceptable indicators of the
main components of the ICF. This provides investigators
with a means to reanalyze PDQ-39 data from an ICF per-
spective and to study its health components using a widely
available health status questionnaire for people with PD.
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